Storia in 2 fonti

AstraZeneca Pharma India Q1 profit drops to ₹37.93 crore

AstraZeneca Pharma India reports Q1 profit drop to ₹37.93 crore despite revenue growth to ₹682.79 crore amid higher expenses.

Raccontata da

thehindubusinessline.com

economictimes.indiatimes.com

Confronto fonti

2 prospettive sulla stessa storia

AI · summaries

thehindubusinessline.com7 h fa

Zydus Lifesciences Q1 profit falls 36% despite revenue growth

Zydus Q1 profit dropped 36% to ₹940 crore while revenue grew 22% to ₹8,017 crore; EBITDA margin fell to 24.1% from 31.8%. Margin compression signals generic sector pressure in North America (-3%), offset by branded portfolio shift (55% revenue) and specialty M&A (Assertio).

Leggi questa versione → originale

economictimes.indiatimes.com6 h fa

Zydus Lifesciences Q1 Results: Net profit down 36% at Rs 939.8 crore

Questo articolo non è tech-relevant per Warptech Tech News. Riguarda i risultati finanziari di Zydus Lifesciences (pharma india), privo di implicazioni su AI, infrastrutture, software, decisioni di stack o governance tech. Non genero un riassunto.

Leggi questa versione →

Timeline cronologica

lunedì 10 agosto 2026·thehindubusinessline.com
AstraZeneca Pharma India Q1 profit drops to ₹37.93 crore
AstraZeneca Pharma India reports Q1 profit drop to ₹37.93 crore despite revenue growth to ₹682.79 crore amid higher expenses.
martedì 11 agosto 2026·thehindubusinessline.com
Zydus Lifesciences Q1 profit falls 36% despite revenue growth
Zydus Lifesciences Ltd reported a 36% year-on-year decline in consolidated net profit to ₹939.8 crore for the first quarter of FY27, even as revenue from operations grew 22% to…